Establishment Labs Holdings Inc. (NASDAQ:ESTA) Receives Average Rating of "Moderate Buy" from Brokerages

Establishment Labs Holdings Inc. (NASDAQ:ESTA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the five research firms that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $52.40.

Several research firms have recently commented on ESTA. Wall Street Zen raised shares of Establishment Labs from a "sell" rating to a "hold" rating in a report on Saturday, June 14th. Needham & Company LLC reiterated a "buy" rating and issued a $48.00 price objective on shares of Establishment Labs in a research report on Friday, June 13th. Stephens reiterated an "overweight" rating and issued a $52.00 price objective on shares of Establishment Labs in a research report on Thursday, March 6th. Finally, BTIG Research began coverage on shares of Establishment Labs in a research report on Friday, May 16th. They issued a "buy" rating and a $62.00 price objective on the stock.

Institutional Trading of Establishment Labs

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Brown Advisory Inc. raised its position in shares of Establishment Labs by 23.1% during the 4th quarter. Brown Advisory Inc. now owns 2,338,369 shares of the company's stock worth $107,729,000 after buying an additional 438,057 shares in the last quarter. Capital Research Global Investors raised its position in shares of Establishment Labs by 29.3% during the 4th quarter. Capital Research Global Investors now owns 1,911,525 shares of the company's stock worth $88,064,000 after buying an additional 433,484 shares in the last quarter. Nantahala Capital Management LLC raised its position in shares of Establishment Labs by 7.2% during the 1st quarter. Nantahala Capital Management LLC now owns 1,774,044 shares of the company's stock worth $72,390,000 after buying an additional 119,574 shares in the last quarter. Findell Capital Management LLC raised its position in shares of Establishment Labs by 28.5% during the 4th quarter. Findell Capital Management LLC now owns 1,346,480 shares of the company's stock worth $62,032,000 after buying an additional 298,380 shares in the last quarter. Finally, Rice Hall James & Associates LLC raised its position in shares of Establishment Labs by 7.4% during the 1st quarter. Rice Hall James & Associates LLC now owns 827,423 shares of the company's stock worth $33,763,000 after buying an additional 56,756 shares in the last quarter. 72.91% of the stock is currently owned by institutional investors.

Establishment Labs Stock Performance

Shares of NASDAQ ESTA traded up $0.09 during midday trading on Friday, hitting $40.93. The company's stock had a trading volume of 471,003 shares, compared to its average volume of 474,233. Establishment Labs has a 1-year low of $26.56 and a 1-year high of $52.41. The firm's fifty day moving average price is $35.37 and its 200-day moving average price is $36.85. The company has a debt-to-equity ratio of 5.72, a quick ratio of 2.05 and a current ratio of 3.36. The firm has a market cap of $1.18 billion, a P/E ratio of -13.20 and a beta of 0.74.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported ($0.70) EPS for the quarter, beating the consensus estimate of ($0.83) by $0.13. Establishment Labs had a negative net margin of 52.34% and a negative return on equity of 196.25%. The business had revenue of $41.38 million during the quarter, compared to analyst estimates of $41.15 million. During the same period in the previous year, the business posted ($0.58) EPS. The company's quarterly revenue was up 11.3% on a year-over-year basis. On average, sell-side analysts forecast that Establishment Labs will post -2.41 EPS for the current fiscal year.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.